Table 3.
Secondary outcomes: anthropometric and blood parameters before and after intervention1 according to randomisation.
| Control | Intervention | P ∗ | |||
|---|---|---|---|---|---|
| Week 0 n = 38 |
Week 12 n = 38 |
Week 0 n = 32 |
Week 12 n = 32 |
||
| Weight (Kg) | 89.4 (14.9) | 89.4 (14.7) | 89.4 (13.7) | 89.8 (13.8) | 0.47 |
| BMI (Kg/m2) | 31.3 (4.6) | 31.3 (4.5) | 31.3 (5.1) | 31.4 (5.0) | 0.81 |
| Waist circumference (cm) | 109.0 (11.7) | 108.5 (11.6) | 108.4 (10.1) | 107.5 (9.8) | 0.56 |
| Hip circumference (cm) | 114.9 (8.9) | 114.3 (8.8) | 114.2 (10.5) | 114.4 (11.2) | 0.47 |
| Waist: hip | 0.95 (0.07) | 0.95 (0.07) | 0.95 (0.06) | 0.92 (0.16) | 0.16 |
| Systolic blood pressure (mm/Hg) | 137 (15.2) | 137 (15.1) | 137 (14.9) | 138 (14.2) | 0.89 |
| Diastolic blood pressure (mm/Hg) | 82 (8.5) | 83 (8.6) | 85 (7.4) | 85 (9.2) | 0.83 |
| Total cholesterol (mmol/L) | 4.3 (1.2) | 4.2 (1.0) | 4.4 (1.07) | 4.3 (0.96) | 0.52 |
| HDL cholesterol (mmol/L) | 1.2 (0.27) | 1.2 (0.33) | 1.2 (0.32) | 1.2 (0.30) | 0.75 |
| Calculated LDL cholesterol (mmol/L) | 2.3 (0.97) | 2.1 (0.91) | 2.4 (0.93) | 2.2 (0.77) | 0.66 |
| Triglycerides (mmol/L) | 1.9 (0.70) | 1.9 (1.04) | 1.7 (0.75) | 1.9 (0.94) | 0.36 |
| HbA1c (DCCT%) | 6.4 (1.1) | 6.5 (1.1) | 6.4 (0.9) | 6.4 (0.8) | 0.94 |
| Fasting glucose (mmol/L) | 8.2 (2.5) | 8.1 (2.3) | 7.7 (1.8) | 8.3 (1.9) | 0.12 |
| Insulin (mU/L) | 12.8 (7.9) | 16.2 (14.9) | 15.4 (13.8) | 19.8 (25.1) | 0.43 |
1Data given as mean (standard deviation).
∗Between groups at week 12 after controlling for baseline (one-way ANCOVA).